60 related articles for article (PubMed ID: 1437800)
1. [Diarrhea caused by Campylobacter in patients with hematologic diseases].
Fischer W; Gościniak G; Gałazka Z
Pol Tyg Lek; 1992 Feb 3-10; 47(5-6):131-2. PubMed ID: 1437800
[TBL] [Abstract][Full Text] [Related]
2. Full-dose chemotherapy for non-Hodgkin's lymphoma in the elderly. Dutch Hematology-Oncology in Adults Study Group.
Sonneveld P; Hop W; Mulder AH; Michiels JJ; Blijham G; van de Lelie J; Raemakers JW; Nieuwenhuis K; van der Heul C
Semin Hematol; 1994 Apr; 31(2 Suppl 3):9-12. PubMed ID: 8073309
[No Abstract] [Full Text] [Related]
3. Long-term follow-up of non-Hodgkin's lymphoma patients treated with ProMACE-CytaBOM: an effective regimen for the intermediate grade subtype.
Marotta G; Bigazzi C; Bocchia M; Forconi F; Lauria F
Haematologica; 1998 Sep; 83(9):853-4. PubMed ID: 9825583
[TBL] [Abstract][Full Text] [Related]
4. Avascular necrosis of bone mimicking symmetric polyarthritis in a patient with malignant lymphoma treated with high-dose steroids.
Buskila D; Thomson GT; Klein M; Keystone EC
Isr J Med Sci; 1992 Nov; 28(11):804-5. PubMed ID: 1281809
[No Abstract] [Full Text] [Related]
5. Disseminated strongyloidiasis and cytomegalovirus infection in a patient with anaplastic large cell lymphoma.
Rehman JU; Rao TV; AlKindi S; Dennison D; Pathare AV
Ann Hematol; 2007 Dec; 86(12):925-6. PubMed ID: 17641892
[No Abstract] [Full Text] [Related]
6. Risk and timing of hospitalization for febrile neutropenia in patients receiving CHOP, CHOP-R, or CNOP chemotherapy for intermediate-grade non-Hodgkin lymphoma.
Lyman GH; Delgado DJ
Cancer; 2003 Dec; 98(11):2402-9. PubMed ID: 14635075
[TBL] [Abstract][Full Text] [Related]
7. [Clinical usefulness of ondansetron hydrochloride for nausea and vomiting during repeated courses of chemotherapy for malignant lymphoma--impact of prognosis announcement on anti-emetic effect and evaluation of patient perception of chemotherapy-associated adverse events].
Kodama F; Mohri H; Motomura S; Fukawa H; Tanabe J; Koharasawa H; Kanamori H; Hashimoto Y; Harano H; Sakai R; Tomita N; Fujimaki K; Takemura S; Hattori M
Gan To Kagaku Ryoho; 2002 Feb; 29(2):273-9. PubMed ID: 11865634
[TBL] [Abstract][Full Text] [Related]
8. Comparison of front-line chemotherapy for aggressive non-Hodgkin's lymphoma using the CAP-BOP regimens. The Nebraska Lymphoma Study Group.
Vose JM; Anderson JR; Bierman PJ; Bast M; Weisenburger D; Chan WC; Bishop MR; Armitage JO
Semin Hematol; 1994 Apr; 31(2 Suppl 3):4-8. PubMed ID: 7521065
[No Abstract] [Full Text] [Related]
9. [THP-COP, BHAC-VMP alternating chemotherapy in patients with non-Hodgkin's lymphoma].
Imura H; Ito N; Shirakawa S; Sobue R; Maruyama F; Kojima H; Shinkai K; Matsui T; Ino T; Shimizu K
Rinsho Ketsueki; 1988 May; 29(5):688-93. PubMed ID: 3216495
[No Abstract] [Full Text] [Related]
10. A phase I trial to assess the value of recombinant human granulocyte colony stimulating factor (R-MeTHuG-CSF, filgrastim) in accelerating the dose rate of chemotherapy for intermediate and high-grade non-Hodgkin's lymphoma (NHL). The Central Lymphoma Group.
Smith GM; Child JA; Cullen MH; Bailey NP; Woodruffe CM; Fletcher J; Earl H; Barnard D
Hematol Oncol; 1996 Dec; 14(4):193-201. PubMed ID: 9267465
[TBL] [Abstract][Full Text] [Related]
11. CBVPM/AVBP versus HCOMLA chemotherapy in non-Hodgkin lymphoma patients.
Pawelski S; Konopka L; Pakulska J; Gutkowska J
Chemioterapia; 1987 Jun; 6(2 Suppl):716-9. PubMed ID: 2475265
[No Abstract] [Full Text] [Related]
12. Stevens-Johnson syndrome associated with methotrexate treatment for non-Hodgkin's lymphoma.
Cuthbert RJ; Craig JI; Ludlam CA
Ulster Med J; 1993 Apr; 62(1):95-7. PubMed ID: 7685956
[No Abstract] [Full Text] [Related]
13. [Comparison of effectiveness of adriamycin and epirubicin administered in the CHOP protocol to patients with malignant non-hodgkin's lymphoma].
Rolski J; Koralewski P; Pawlicki M
Wiad Lek; 1993 May; 46(9-10):356-9. PubMed ID: 8236992
[TBL] [Abstract][Full Text] [Related]
14. [Non-Hodgkin's lymphoma in children. Study of 30 patients at the Caracas University Hospital].
Acquatella G; Urdaneta N; Rosas Uribe A; García Guevara R
Sangre (Barc); 1985; 30(3):253-83. PubMed ID: 3839940
[No Abstract] [Full Text] [Related]
15. CHOP versus CNOP (N = mitoxantrone) in non-Hodgkin's lymphoma: an interim report comparing efficacy and toxicity.
Brusamolino E; Bertini M; Guidi S; Vitolo U; Inverardi D; Merante S; Colombo A; Resegotti L; Bernasconi C; Ferrini PR
Haematologica; 1988; 73(3):217-22. PubMed ID: 3139519
[No Abstract] [Full Text] [Related]
16. Increasing chemotherapy dose density and intensity: phase I trials in non-small cell lung cancer and non-Hodgkin's lymphoma.
Blayney DW; McGuire BW; Cruickshank SE; Johnson DH
Oncologist; 2005 Feb; 10(2):138-49. PubMed ID: 15709216
[TBL] [Abstract][Full Text] [Related]
17. Fatal strongyloidiasis latent over 42 years in the antineoplastic chemotherapy of a case with malignant lymphoma.
Suzuki T; Nara N; Miyake S; Eishi Y; Sugiyama E; Aoki N
Jpn J Med; 1989; 28(1):96-9. PubMed ID: 2470940
[TBL] [Abstract][Full Text] [Related]
18. Coeliac disease following high-dose chemotherapy.
Stewart AJ; Southcott BM
Clin Oncol (R Coll Radiol); 2002 Dec; 14(6):494-6. PubMed ID: 12512973
[TBL] [Abstract][Full Text] [Related]
19. [Metabolic disorders in the treatment of malignant hematologic diseases--the acute tumor lysis syndrome].
Nielsen SH; Hasselbalch HC; Birgens HS
Ugeskr Laeger; 1991 Oct; 153(42):2952-3. PubMed ID: 1949322
[TBL] [Abstract][Full Text] [Related]
20. [Gastrointestinal lymphomas: results of multimodal therapy in 57 patients of one center].
Kiene J; Sezer O; Rasche H; Klempa I
Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():244-6. PubMed ID: 9101844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
